MEMS  

 
  MEMS  
About MEMS   |   Council   |   Members Centre   |   Membership   |   Contact Us   |   Home
  Member Login     username:     password:           Forgot your password?
  Home » Announcements & Updates » 
President’s Message
The Endocrine Directory
Calendar of Events
Announcements & Updates
Breaking News & Reports
CME
CPG
In the Press
Disease Areas
Healthy Lifestyle
Publications
Research Programs
Awards
Photo & Video Gallery
Useful Links
Disease Management
Home
 
arrow Expert commentary from Mayer B. Davidson, MD On RECORD:
8-06-2009
Rosiglitazone was a commonly used thiazolidinedione (TZD) until several years ago, when Dr Steven Nissen published a meta-analysis on the effect of this glitazone on myocardial infarction (MI). He used published and unpublished data on rosiglitazone, and the result of the meta-analysis was that there was a significantly increased risk for the glitazone on MI and death from MI.
»Read more...
 


arrow Session Title: Presentation of the International Expert Committee Report on the Role of A1C Testing to Diagnose Diabetes
8-06-2009
New joint recommendations from the International Diabetes Federation (IDF), European Association for the Study of Diabetes (EASD), and American Diabetes Association (ADA) conclude that A1C should be the new standard test for diagnosing diabetes.
»Read more...
 


arrow Session Title: Results of the RECORD Clinical Trial
8-06-2009
Results from the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) trial found that the thiazolidinedione, rosiglitazone, added to standard glucose-lowering monotherapy does not increase overall risk for cardiovascular morbidity or mortality
»Read more...
 


arrow The MEMS E-Initiative: Objectives of the Website
25-05-2009
A brief outline of the objectives of this website.
»Read more...
 


 
   
 



 
 
| | | |
© Copyright Malaysian Endocrine & Metabolic Society (MEMS)   2009 - 2016    All rights reserved.
designed & maintained: mobition